Previous Close | 195.73 |
Open | 194.80 |
Bid | 0.00 x 900 |
Ask | 194.50 x 800 |
Day's Range | 191.82 - 196.07 |
52 Week Range | 135.85 - 199.95 |
Volume | |
Avg. Volume | 5,220,793 |
Market Cap | 341.698B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 64.48 |
EPS (TTM) | 3.00 |
Earnings Date | Oct 25, 2024 - Oct 29, 2024 |
Forward Dividend & Yield | 6.20 (3.20%) |
Ex-Dividend Date | Oct 15, 2024 |
1y Target Est | 197.33 |
AbbVie (ABBV) closed at $193.45 in the latest trading session, marking a -1.16% move from the prior day.
RHHBY vs. ABBV: Which Stock Is the Better Value Option?
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?